FdaApplication
ANDA 211626
Identifiers
- fda_app_no: ANDA211626
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2019-07-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FENOFIBRIC ACID | CHOLINE FENOFIBRATE | EQ 45MG FENOFIBRIC ACID | CAPSULE, DELAYED RELEASE;ORAL |
| FENOFIBRIC ACID | CHOLINE FENOFIBRATE | EQ 135MG FENOFIBRIC ACID | CAPSULE, DELAYED RELEASE;ORAL |
2 products